{"disease":{"id":"ibs-d-diarrhea-predominant","name":"ibs d diarrhea predominant"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07168434","title":"Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":406,"lead_sponsor_name":"Biocodex","has_results":false},{"nct_id":"NCT06676514","title":"Study to Evaluate the Treatment Benefits of Probiotic Clostridium Butyricum CBM588® for IBS-D","phase":"NA","overall_status":"COMPLETED","enrollment_count":405,"lead_sponsor_name":"Liaquat University of Medical & Health Sciences","has_results":false},{"nct_id":"NCT06727422","title":"Efficacy of Rifaximin With NAC in IBS-D","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":225,"lead_sponsor_name":"Mark Pimentel, MD","has_results":false},{"nct_id":"NCT07520422","title":"Bacillus Coagulans Based Product in IBS-Diarrhea","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Bioagile Therapeutics Pvt. Ltd.","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}